Mathias Chea

Dr. Mathias Chea

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MCMathias Chea
Mathias Chea
LRLucie Rigolot
Lucie Rigolot
ACAlban Canali
Alban Canali
FVFrancois Vergez
Francois Vergez
Minimal residual disease (MRD) is of major importance in onco-hematology, particularly in acute myeloid leukemia (AML). MRD measures the amount of leukemia cells remaining in a patient after treatment, and is an essential tool for disease monitoring, relapse prognosis, and guiding treatment decisions. Patients with a negative MRD tend to have superior disease-free and overall survival rates. Considerable effort has been made to standardize MRD practices. A variety of techniques, including flow cytometry and molecular methods, are used to assess MRD, each with distinct strengths and weaknesses. MRD is recognized not only as a predictive biomarker, but also as a prognostic tool and marker of treatment efficacy. Expected advances in MRD assessment encompass molecular techniques such as NGS and digital PCR, as well as optimization strategies such as unsupervised flow cytometry analysis and leukemic stem cell monitoring. At present, there is no perfect method for measuring MRD, and significant advances are expected in the future to fully integrate MRD assessment into the management of AML patients.

21 December 2023 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
MCMathias Chea
Mathias Chea
CBChloé Bourguignon
Chloé Bourguignon
SBSylvie Bouvier
Sylvie Bouvier
ENEva Nouvellon
Eva Nouvellon
JLJeremy Laurent
Jeremy Laurent
Jean-Christophe Raymond GRISJean-Christophe Raymond GRIS
Jean-Christophe Raymond GRIS

2 January 2023 in Thrombosis Research
Verified
Journal Article
Closed access
Jean-Christophe Raymond GRISJean-Christophe Raymond GRIS
Jean-Christophe Raymond GRIS
FGFlorence Guillotin
Florence Guillotin
TSTaissa PEREIRA DOS SANTOS
Taissa PEREIRA DOS SANTOS
MCMathias Chea
Mathias Chea
PLPaul Loubet
Paul Loubet
AMAntonia Perez Martin
Antonia Perez Martin

18 December 2024 in Thrombosis and Haemostasis
Verified
Journal Article
Closed access
PDF file
VBVictoria Bitsadze
Victoria Bitsadze
МНМария Геннадьевна Николаева
Мария Геннадьевна Николаева
ÈMÈve Mousty
Ève Mousty
JKJamilya Khizroeva
Jamilya Khizroeva
JLJérémy Laurent
Jérémy Laurent
Jean-Christophe Raymond GRISJean-Christophe Raymond GRIS
Jean-Christophe Raymond GRIS
Background In young women with venous thromboembolism (VTE) related to weak transient risk factors, it remains unknown whether stress levels and intimate partner violence (IPV) are associated with recurrence. The VTE-WEAK study aims to investigate the association between perceived stress and IPV with a recurrence of VTE in women with a first episode of VTE due to combined oral contraceptives, pregnancy-puerperium, minor trauma/fracture, brief surgery, infection or brief immobility, and not using antithrombotic prophylaxis. Material and Methods We performed a multicenter, international, observational, retrospective study on women referred for thrombophilia screening who were subsequently monitored. Patients were aged 18 to 55 years old and free of high-risk thrombophilia. When a recurrence of VTE was suspected for the first time, the perceived stress level and IPV were evaluated using self-administrated PSS-10 and Woman Abuse Screening Tool (WAST) questionnaires. Results We monitored 7,754 women over 43,880 patients–years. A first suspected recurrence occurred in 4,772 women, among whom 1,316 had an objectively confirmed recurrence. The perceived stress level and an IPV situation were both independent risk factors for recurrence: moderate stress: adjusted odds ratio (aOR) 1.630 (1.415–2.468); high perceived stress: aOR 10.03 (7.528–13.36); IPV: 1.953 (1.546–2.468), p < 0.0001. Conclusion The perceived level of stress and IPV are associated with a recurrence of VTE when suspected. The mechanisms and clinical consequences of a possible stress coagulopathy require investigation.

17 September 2024 in Thrombosis Research
Verified
Journal Article
Closed access
MCMathias Chea
Mathias Chea
SBSylvie Bouvier
Sylvie Bouvier
JGJean-Christophe Gris
Jean-Christophe Gris

15 July 2025 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
VBVictoria Bitsadze
Victoria Bitsadze
МНМария Геннадьевна Николаева
Мария Геннадьевна Николаева
EMEve Mousty
Eve Mousty
JKJamilya Khizroeva
Jamilya Khizroeva
JLJeremy Laurent
Jeremy Laurent
Jean-Christophe Raymond GRISJean-Christophe Raymond GRIS
Jean-Christophe Raymond GRIS